维普中文期刊产品整合服务
83篇 您的检索式:作者名="Narod SA"
    题名 作者 年代 出处 被引量
1Methylation ofthe BRCA1 promoter in peripheral blood DNA is associated with triple- negative and medullary breast cancer显示文摘Gupta S Jaworska - Bieniek K Narod SA 2014Breast Cancer Res Treat2014,148,:1
2CHEK2 mutation and hereditary breast cancer显示文摘Narod SA Lynch HT 2007JClinOncol2007,25,1:1
3Family history and the risk of gastric cancer 显示文摘Yaghoobi M Bijarchi R Narod SA 2010Br J Cancer2010,102,23:1
4Tubal ligation and risk of ovarian cancer in carriers of BRCAl or BRCA2mutations:a case-control study显示文摘Narod SA Sun P Ghadirian P 2001Lancet2001,357,:1
5The role of reexcision for positive margins in optimizing local disease control after breast-conserving surgery for cancer显示文摘Aziz D Rawlinson E Narod SA 2006Breast J2006,12,4:1
6BRCA1 and BRCA2:1994 and beyond 显示文摘Narod SA Foulkes WD 2004Nature Rev Cancer2004,4,9:1
7Breast cancer risk reduction associated with the RAD51 polymorphism among carriers of the BRCA1 5382insC mutation in Poland显示文摘Jakubowska A Narod SA Goldgar DE 2003Cancer Epidemiol Biomarkers Pre2003,12,:1
8BRCAl and BRCA2:1994 and beyond显示文摘Narod SA Foulkes WD 2004Nat Rev Cancer2004,4,9:1
9Impact of boost radiation in the treatment of ductal carcinoma in situ: a population-based analysis显示文摘Rakovitch E Narod SA Nofech-Moses S 2013Int J Radiat Oncol Biol Phys2013,86,3:1
10Breast cancer risk reduction associated with the RAD51 polymorphism among carri- ers of the BRCA1 5382insc mutation in Poland显示文摘Jakubowska A Narod SA Goldgar DE 2003Cancer Epi- demiol Biomarkers Prey2003,12,5:1
11Oral contraceptives and hereditary breast and ovarian cancer Y CME review article 541the risk of hereditary ovarian cancer显示文摘Narod SA Risch H Moslehi R 1998N Engl J Med1998,339,:1
12Tubal ligation and risk of ovarian cancer in carriers of BRCA1 or BRCA2 mutations:a case-control study显示文摘Narod SA Sun P Ghadirian P 2001Lancet2001,357,:1
13Familial breast-o-varian cancer locus on chromosome 17q12-q23显示文摘Narod SA Feunteun J Lynch HT 1991Lan-cet1991,338,8759:1
14Tubal ligation and risk of ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control study 显示文摘Narod SA Sun P Ghadirian P 2001Lancet2001,357,9267:1
15BRCA1 and BRCA2:1994 and beyond显示文摘Narod SA Foulkes WD 2004Nat Rev Cancer2004,4,9:1
16Tamoxifen for women at high risk of breast cancer显示文摘Nazarali SA Narod SA 2014Breast Cancer (Dove Med Press)2014,6,:1
17Current understanding of the epidemiology and clinical implications of BRCA1 and BRCA2 mutations for ovarian cancer显示文摘Narod SA Boyd J 2002Curr Opin Obstet Gynecol2002,14,:1
18A prospective study of mastectomy patients with and without delayed breast reconstruction:long-term psychosocial functioning in the breast cancer survivorship period显示文摘Metcalfe KA Zhong T Narod SA 2015J Surg Oncol2015,111,3:1
19Tumour size predicts long-term survival among women with lymph node- positive breast cancer 显示文摘Narod SA 2012Curr Oncol2012,19,5:1
20Fusion in the ETS gene family and prostate cancer显示文摘Narod SA Seth A Nam R 2008Br J Cancer2008,99,6:1
返回顶部 每页显示:
共5页 首页 上一页 第1页 下一页 末页 /5 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费